Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
3p-hpRNA - RIG-I agonist TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is ... 2022 Nucleic Acids Res Choudhury N.R. et al. DOI: 10.1093/nar/gkac512
IFN-α/β Reporter HEK 293 Cells TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is ... 2022 Nucleic Acids Res Choudhury N.R. et al. DOI: 10.1093/nar/gkac512
Poly(I:C) HMW Human Beta Papillomavirus Type 8 E1 and E2 Proteins Suppress the Activation o... 2022 Viruses Rattay S. et al. DOI: 10.3390/v14071361
IFN-α/β Reporter HEK 293 Cells Human Beta Papillomavirus Type 8 E1 and E2 Proteins Suppress the Activation o... 2022 Viruses Rattay S. et al. DOI: 10.3390/v14071361
Poly(I:C) HMW Simulation of COVID-19 symptoms in a genetically engineered mouse model: impl... 2022 Mol Cell Biochem. Singh M. et al. DOI: 10.1007/s11010-022-04487-0
LPS-EB (LPS from E. coli O111:B4) Distinct responses between healthy and cirrhotic human livers upon lipopolysa... 2022 Am J Physiol Gastrointest Liver Physiol. Suriguga S. et al. DOI: 10.1152/ajpgi.00243.2021
QUANTI-Luc™: Luciferase Detection Reagent Antibody-based redirection of universal Fabrack-CAR T cells selectively kill ... 2022 J Immunother Cancer Kuo Y.C. et al. DOI: 10.1136/jitc-2021-003752
Jurkat Reporter Cells (NFAT) Antibody-based redirection of universal Fabrack-CAR T cells selectively kill ... 2022 J Immunother Cancer Kuo Y.C. et al. DOI: 10.1136/jitc-2021-003752
LPS-EB (LPS from E. coli O111:B4) Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by e... 2022 Respir Res. Qin W. et al. DOI: 10.1186/s12931-022-02088-5
Puromycin Cancer cells resist antibody-mediated destruction by neutrophils through acti... 2022 J Immunother Cancer van Rees D.J. et al. DOI: 10.1136/jitc-2022-004820
ODN 2216 - TLR9 ligand The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blo... 2022 Front Med (Lausanne) Rosa T.L.S.A. et al. DOI: 10.3389/fmed.2022.899998
QUANTI-Blue™ The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blo... 2022 Front Med (Lausanne) Rosa T.L.S.A. et al. DOI: 10.3389/fmed.2022.899998
IFN-α/β Reporter HEK 293 Cells The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blo... 2022 Front Med (Lausanne) Rosa T.L.S.A. et al. DOI: 10.3389/fmed.2022.899998
Puromycin Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells... 2022 Am J Pathol. Muresan X.M. et al. DOI: 10.1016/j.ajpath.2022.05.009
TLR 3 - DN Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells... 2022 Am J Pathol. Muresan X.M. et al. DOI: 10.1016/j.ajpath.2022.05.009
Poly(I:C) HMW Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells... 2022 Am J Pathol. Muresan X.M. et al. DOI: 10.1016/j.ajpath.2022.05.009
Bafilomycin A1 Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells... 2022 Am J Pathol. Muresan X.M. et al. DOI: 10.1016/j.ajpath.2022.05.009
Pam2CSK4 Sulfavant A as the first synthetic TREM2 ligand discloses a homeostatic respo... 2022 Cell Mol Life Sci. Gallo C. et al. DOI: 10.1007/s00018-022-04297-z
HEK-Blue™ hDectin-1b Cells Sulfavant A as the first synthetic TREM2 ligand discloses a homeostatic respo... 2022 Cell Mol Life Sci. Gallo C. et al. DOI: 10.1007/s00018-022-04297-z
HEK-Blue™ Detection Sulfavant A as the first synthetic TREM2 ligand discloses a homeostatic respo... 2022 Cell Mol Life Sci. Gallo C. et al. DOI: 10.1007/s00018-022-04297-z

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty